Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholder's Equity (Unaudited)

v3.22.1
Consolidated Statements of Stockholder's Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional paid-in capital [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Beginning Balance at Dec. 31, 2020 $ 37,286 $ 76 $ 97,640 $ 4 $ (60,434)
Beginning Balance, Shares at Dec. 31, 2020   6,111,735      
Stock-based compensation expense 542   542    
Shares issued on exercise of warrants 236   236    
Shares issued on exercise of warrants, Shares   35,217      
Shares issued as settlement with trade vendor 23   23    
Shares issued as settlement with trade vendor, Shares   2,965      
Net loss (7,999)       (7,999)
Ending Balance at Mar. 31, 2021 30,088 $ 76 98,441 4 (68,433)
Ending Balance, Shares at Mar. 31, 2021   6,149,917      
Beginning Balance at Dec. 31, 2021 28,042 $ 79 121,545 4 (93,586)
Beginning Balance, Shares at Dec. 31, 2021   9,453,542      
Stock-based compensation expense 823   823    
Shares issued on exercise of warrants 24   24    
Shares issued on exercise of warrants, Shares   3,709      
Shares issued from purchase agreement with Virtu 91   91    
Shares issued from purchase agreement with Virtu, Shares   12,742      
Shares issued as settlement with trade vendor 26   26    
Shares issued as settlement with trade vendor, Shares   3,584      
Net loss (7,573)       (7,573)
Ending Balance at Mar. 31, 2022 $ 21,433 $ 79 $ 122,509 $ 4 $ (101,159)
Ending Balance, Shares at Mar. 31, 2022   9,473,577